Through innovative research and development of high-quality drugs to serve patients, we focus our technology and resources on a series of priority products and platforms, and achieve a leading position in the field of research and development: the latest dosage form of external medicine ----gel; At the same time, we also pay close attention to the cooperation and opportunities in the field of extracorporeal use of human genes, such as ent, rub and enema.
       Due to climate change, environmental pollution and other factors, dermatology and ent drugs account for the following:
       30.57% in China
       36.5% In west Africa
       20.5% in southeast Asia
       19.54% in Latin America
       18.3% In Europe
       21% in Asia